Source link : https://www.newshealth.biz/health-news/fda-approves-omalizumab-for-multiple-food-allergy/
The US Food and Drug Administration (FDA) has approved omalizumab injection (Xolair, Genentech) for children aged 1 year or older and adults to reduce immunoglobulin E─mediated severe allergy to multiple food items. Omalizumab is intended for repetitive use to lower the risk for allergic reactions. However, it is important to note that it has not […]
Author : News Health
Publish date : 2024-02-29 07:59:09
Copyright for syndicated content belongs to the linked Source.
Categories